436.05
+3.00
+(0.69%)
As of 2:49:46 PM GMT+5:30. Market Open.
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
--
1,867,160
3,153,090
2,937,330
2,290,180
Investing Cash Flow
--
-1,737,450
-2,923,400
-2,843,710
-1,561,960
Financing Cash Flow
--
-269,980
-76,800
-55,580
-968,680
End Cash Position
--
127,030
267,300
114,000
76,360
Capital Expenditure
--
-2,041,960
-3,026,200
-2,733,140
-1,575,990
Issuance of Debt
--
350,000
2,900,000
1,350,000
600,000
Repayment of Debt
--
-837,230
-1,212,270
-887,130
-872,600
Free Cash Flow
--
-174,800
126,890
204,190
714,190
3/31/2021 - 1/3/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BAJAJHCARE.BO Bajaj HealthCare Limited
625.75
+0.45%
PARMAX.BO Parmax Pharma Limited
39.06
-9.16%
AARTIPHARM.BO Aarti Pharmalabs Limited
731.15
+1.95%
ANUHPHR.BO Anuh Pharma Limited
172.50
-0.69%
GLENMARK.BO Glenmark Pharmaceuticals Limited
1,346.80
-0.75%
NEULANDLAB.BO Neuland Laboratories Limited
12,950.00
+1.63%
SUVEN.NS Suven Life Sciences Limited
126.60
+0.36%
GLAND.NS Gland Pharma Limited
1,450.00
+0.51%
NEULANDLAB.NS Neuland Laboratories Limited
12,888.00
+1.09%
LAURUSLABS.BO Laurus Labs Limited
628.15
+0.22%